Global Enteral Feeding Formula Market – Industry Trends and Forecast to 2031

Enteral Feeding Formula Market Analysis and Size

The enteral feeding formula market is advancing rapidly, driven by innovations in formulation and delivery technology. Latest methods include peptide-based and disease-specific formulas, enhancing nutrient absorption and patient outcomes. Growth is propelled by rising chronic disease prevalence and an aging population, with smart pumps and real-time monitoring boosting efficiency and safety in clinical and home settings.                                

The global enteral feeding formula market size was valued at USD 3.56 billion in 2023, is projected to reach USD 6.20 billion by 2031, with a CAGR of 7.20% during the forecast period 2024 to 2031. This indicates that the market value. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Market Definition

Enteral feeding formula is a nutritionally balanced liquid diet delivered directly to the gastrointestinal tract through a tube. It is used for individuals unable to consume food orally, providing essential nutrients, including proteins, fats, carbohydrates, vitamins, and minerals. Formulas vary based on specific medical needs and digestive capabilities, ensuring adequate nutrition and hydration for patients.            

Enteral Feeding Formula Market Dynamics

Drivers

• Increasing Prevalence of Chronic Diseases

The increasing prevalence of chronic diseases such as cancer, diabetes, and gastrointestinal disorders drives the demand for enteral feeding formulas. For instance, cancer patients undergoing chemotherapy often experience severe nausea and appetite loss, making it difficult to maintain adequate nutrition through regular food intake. Enteral feeding formulas provide essential nutrients, supporting patient recovery and overall health, thereby fueling market growth.

• Growing Incidence of Swallowing Disorders

The growing incidence of swallowing disorders, such as dysphagia, significantly drives the enteral feeding formula market. Both elderly patients and younger individuals with conditions such as stroke, Parkinson's disease, or neurological impairments often require enteral feeding for proper nutrition. For instance, a stroke patient with severe dysphagia might rely on enteral tube feeding formulas to meet their nutritional needs, thus fueling the demand for these specialized products.

Opportunities

• Rising Home Healthcare Growth

The growth of home healthcare services is significantly boosting the market for home-based enteral nutrition products. This trend allows patients with chronic conditions or those recovering from surgeries to receive essential nutritional support in the comfort of their homes. For instance, elderly individuals recovering from gastrointestinal surgeries can now maintain their nutritional intake effectively with specialized enteral feeding formulas, driving demand and innovation in this sector.

• Rising Nutritional Management of Cancer Patients

Enteral feeding plays a crucial role in managing nutrition for cancer patients undergoing chemotherapy or radiotherapy, who often face challenges in consuming sufficient regular meals due to treatment side effects. For instance, patients with head and neck cancers may experience swallowing difficulties (dysphagia), making enteral feeding via feeding tubes essential for maintaining adequate nutrition levels. This necessity significantly drives the demand for enteral feeding formulas tailored to meet the nutritional needs of cancer patients. 

Restraints/Challenges

• Risk of Contamination

The risk of contamination in enteral feeding formulas, if mishandled during production or administration, poses a significant barrier to market acceptance. Strict adherence to hygiene standards is crucial to mitigate this risk, as any compromise can lead to adverse health effects for patients, eroding trust and adoption in the market. 

• Preference for Parenteral Nutrition

Preference for parenteral nutrition over enteral feeding formulas among healthcare providers and patients can hinder market demand due to perceived advantages such as bypassing gastrointestinal issues and ensuring precise nutrient delivery. This preference stems from clinical considerations despite potential drawbacks such as increased infection risks and higher costs associated with parenteral administration.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In September 2023, Abbott announced plans to expand manufacturing of various adult enteral formulas for the retail market, aiming to address shortages in the institutional sector by boosting production capacity and distribution channels
• In 2023, Nestlé and EraCal Therapeutics commenced a collaborative research venture aimed at discovering novel nutraceuticals tailored to regulate food intake. This partnership seeks to leverage their respective expertise to develop innovative solutions that address consumer needs for effective dietary management
• In September 2022, Kate Farms secured USD 75 million in a Series C funding round led by Novo Holdings, enhancing efforts in plant-based clinical nutrition research, product innovation, and expansion across diverse market segments
• In September 2022, Kate Farms introduced Adult Standard 1.4, a high-calorie medical formula now available in chocolate, designed to support weight gain, maintenance, and digestive tolerance while offering a palatable flavor option for consumers

Enteral Feeding Formula Market Scope

The market is segmented on the basis of product, application, type of tube feeding, stage, flavor type, mode of delivery, form, distribution channel, flow type, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Diabetic Formulas
• Hepatic Formulas
• Renal Formulas
• Peptide Based Formulas
• Standard Formulas
• Disease-Specific Formulas
  • Alzheimer’s
  • Nutrition Deficiency
  • Cancer Care
  • Diabetes
  • Chronic Kidney Diseases
  • Orphan Diseases
  • Dysphagia
  • Pain Management
  • Malabsorption/GI Disorder/Diarrhea
  • Others
• Blenderized Formula
• Elemental Formula
• Semi-elemental Formula
• Polymeric Formula
• Hydrolysed Formula
• Fibre-supplemented Formula
• Others

Application

• Oncology
• Neurology
• Critical Care
• Diabetes
• Gastroenterology
• Others

Type of Tube Feeding

• Gastric Tube Feeding
• Nasogastric Tube Feeding
• Gastrostomy Tube Feeding
• Duodenal or Jejunal Tube Feeding

 Stage

• Adult
• Paediatric

 End User

• Hospitals
• Home Care
• Nursing Homes
• Assisted Living Facilities
• Long Term Care Facilities

Flavor Type

• Flavored
  • Vanilla
  •  Strawberry
  •  Butter Pecan
  • Others
• Unflavored

 Mode of Delivery

• Oral
• Gastric
  • Nasogastric
  • Oro-gastric
  • Gastronomy
• Trans-pyloric
  • Naso-jejunal
  • Gastro-jejunostomy
  • Jejunostomy

 Form

• Powder
• Liquid
• Others

  Distribution Channel

• Online Sales
• Retail Sales
• Institutional Sales

Flow Type

• Intermittent Feeding Flow
• Continuous Feeding Flow

Enteral Feeding Formula Market Regional Analysis/Insights

The market is analysed and market size insights and trends are provided by country, product, application, type of tube feeding, stage, flavor type, mode of delivery, form, distribution channel, flow type, and end user as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Asia-Pacific is expected to witness significant growth in the enteral feeding formula market during the forecast period, driven by the availability of types of enteral feeding formulas and rising incidence of preterm births in the region. This trend underscores the increasing demand for specialized nutritional solutions to support neonatal health and development.

North America is expected to dominate the enteral feeding formula market due to its high prevalence of chronic diseases such as cancer, diabetes, and neurological conditions. This demographic drives demand for specialized nutritional support, propelling market growth in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Enteral Feeding Formula Market Share Analysis

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Some of the major players operating in the market are:

• Hormel Foods Corporation (U.S.)
• Global Health Products, Inc. (U.S.)
•  Medline Industries, Inc. (U.S.)
•  Mead Johnson & Company, LLC. (U.S.)
•  Medtrition Inc. (U.S.)
• Nutritional Medicinals, LLC (U.S.)
• Real Food Blends (U.S.)
• Meiji Holdings Co., Ltd. (Japan)
•  Fresenius Kabi AG (Germany)
•  B. Braun SE (Germany)
• Abbott (U.S.)

SKU-23986